Literature DB >> 32269381

Generation of synthetic nanobodies against delicate proteins.

Iwan Zimmermann1,2, Pascal Egloff1,2, Cedric A J Hutter1, Benedikt T Kuhn3, Philipp Bräuer4, Simon Newstead4, Roger J P Dawson2,5, Eric R Geertsma6, Markus A Seeger7.   

Abstract

Here, we provide a protocol to generate synthetic nanobodies, known as sybodies, against any purified protein or protein complex within a 3-week period. Unlike methods that require animals for antibody generation, sybody selections are carried out entirely in vitro under controlled experimental conditions. This is particularly relevant for the generation of conformation-specific binders against labile membrane proteins or protein complexes and allows selections in the presence of non-covalent ligands. Sybodies are especially suited for cases where binder generation via immune libraries fails due to high sequence conservation, toxicity or insufficient stability of the target protein. The procedure entails a single round of ribosome display using the sybody libraries encoded by mRNA, followed by two rounds of phage display and binder identification by ELISA. The protocol is optimized to avoid undesired reduction in binder diversity and enrichment of non-specific binders to ensure the best possible selection outcome. Using the efficient fragment exchange (FX) cloning method, the sybody sequences are transferred from the phagemid to different expression vectors without the need to amplify them by PCR, which avoids unintentional shuffling of complementary determining regions. Using quantitative PCR (qPCR), the efficiency of each selection round is monitored to provide immediate feedback and guide troubleshooting. Our protocol can be carried out by any trained biochemist or molecular biologist using commercially available reagents and typically gives rise to 10-30 unique sybodies exhibiting binding affinities in the range of 500 pM-500 nM.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32269381     DOI: 10.1038/s41596-020-0304-x

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  57 in total

1.  A simple, versatile method for GFP-based super-resolution microscopy via nanobodies.

Authors:  Jonas Ries; Charlotte Kaplan; Evgenia Platonova; Hadi Eghlidi; Helge Ewers
Journal:  Nat Methods       Date:  2012-04-29       Impact factor: 28.547

Review 2.  Challenges and opportunities for non-antibody scaffold drugs.

Authors:  Rodrigo Vazquez-Lombardi; Tri Giang Phan; Carsten Zimmermann; David Lowe; Lutz Jermutus; Daniel Christ
Journal:  Drug Discov Today       Date:  2015-09-07       Impact factor: 7.851

3.  Targeting and tracing antigens in live cells with fluorescent nanobodies.

Authors:  Ulrich Rothbauer; Kourosh Zolghadr; Sergei Tillib; Danny Nowak; Lothar Schermelleh; Anja Gahl; Natalija Backmann; Katja Conrath; Serge Muyldermans; M Cristina Cardoso; Heinrich Leonhardt
Journal:  Nat Methods       Date:  2006-11       Impact factor: 28.547

4.  Modulation of protein properties in living cells using nanobodies.

Authors:  Axel Kirchhofer; Jonas Helma; Katrin Schmidthals; Carina Frauer; Sheng Cui; Annette Karcher; Mireille Pellis; Serge Muyldermans; Corella S Casas-Delucchi; M Cristina Cardoso; Heinrich Leonhardt; Karl-Peter Hopfner; Ulrich Rothbauer
Journal:  Nat Struct Mol Biol       Date:  2009-12-13       Impact factor: 15.369

5.  Structural basis for pH-dependent retrieval of ER proteins from the Golgi by the KDEL receptor.

Authors:  Philipp Bräuer; Joanne L Parker; Andreas Gerondopoulos; Iwan Zimmermann; Markus A Seeger; Francis A Barr; Simon Newstead
Journal:  Science       Date:  2019-03-08       Impact factor: 47.728

6.  Identification of conformation-selective nanobodies against the membrane protein insertase BamA by an integrated structural biology approach.

Authors:  Hundeep Kaur; Jean-Baptiste Hartmann; Roman P Jakob; Michael Zahn; Iwan Zimmermann; Timm Maier; Markus A Seeger; Sebastian Hiller
Journal:  J Biomol NMR       Date:  2019-05-09       Impact factor: 2.835

Review 7.  New concepts and aids to facilitate crystallization.

Authors:  Magdalena A Bukowska; Markus G Grütter
Journal:  Curr Opin Struct Biol       Date:  2013-04-08       Impact factor: 6.809

8.  Conformational nanobodies reveal tethered epidermal growth factor receptor involved in EGFR/ErbB2 predimers.

Authors:  Damien Nevoltris; Benjamin Lombard; Elodie Dupuis; Gérard Mathis; Patrick Chames; Daniel Baty
Journal:  ACS Nano       Date:  2015-01-26       Impact factor: 15.881

Review 9.  Nanobodies to Study G Protein-Coupled Receptor Structure and Function.

Authors:  Aashish Manglik; Brian K Kobilka; Jan Steyaert
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016-12-07       Impact factor: 13.820

10.  A nanobody-based toolset to investigate the role of protein localization and dispersal in Drosophila.

Authors:  Stefan Harmansa; Ilaria Alborelli; Dimitri Bieli; Emmanuel Caussinus; Markus Affolter
Journal:  Elife       Date:  2017-04-11       Impact factor: 8.140

View more
  28 in total

1.  High-efficiency recombinant protein purification using mCherry and YFP nanobody affinity matrices.

Authors:  Anh T Q Cong; Taylor L Witter; Matthew J Schellenberg
Journal:  Protein Sci       Date:  2022-09       Impact factor: 6.993

2.  Nanobodies: From Serendipitous Discovery of Heavy Chain-Only Antibodies in Camelids to a Wide Range of Useful Applications.

Authors:  Fangling Ji; Jun Ren; Cécile Vincke; Lingyun Jia; Serge Muyldermans
Journal:  Methods Mol Biol       Date:  2022

3.  Interaction standards for biophysics: anti-lysozyme nanobodies.

Authors:  Holly L Birchenough; Hilda D Ruiz Nivia; Thomas A Jowitt
Journal:  Eur Biophys J       Date:  2021-04-11       Impact factor: 1.733

Review 4.  Nanobodies for Medical Imaging: About Ready for Prime Time?

Authors:  Léa Berland; Lauren Kim; Omar Abousaway; Andrea Mines; Shruti Mishra; Louise Clark; Paul Hofman; Mohammad Rashidian
Journal:  Biomolecules       Date:  2021-04-26

5.  Structural insights into the binding of nanobodies LaM2 and LaM4 to the red fluorescent protein mCherry.

Authors:  Ziying Wang; Long Li; Rongting Hu; Peiyu Zhong; Yiran Zhang; Shihao Cheng; He Jiang; Rui Liu; Yu Ding
Journal:  Protein Sci       Date:  2021-10-05       Impact factor: 6.725

Review 6.  Recent Advances on Immune Targeted Therapy of Colorectal Cancer Using bi-Specific Antibodies and Therapeutic Vaccines.

Authors:  Ali Azadi; Alireza Golchini; Sina Delazar; Fatemeh Abarghooi Kahaki; Seyed Mohsen Dehnavi; Zahra Payandeh; Shirin Eyvazi
Journal:  Biol Proced Online       Date:  2021-07-01       Impact factor: 3.244

7.  Structures of synthetic nanobody-SARS-CoV-2-RBD complexes reveal distinct sites of interaction and recognition of variants.

Authors:  David Margulies; Javeed Ahmad; Jiansheng Jiang; Lisa Boyd; Allison Zeher; Rick Huang; Di Xia; Kannan Natarajan
Journal:  Res Sq       Date:  2021-06-16

8.  Kinetic mechanism of Na+-coupled aspartate transport catalyzed by GltTk.

Authors:  Gianluca Trinco; Valentina Arkhipova; Alisa A Garaeva; Cedric A J Hutter; Markus A Seeger; Albert Guskov; Dirk J Slotboom
Journal:  Commun Biol       Date:  2021-06-17

9.  Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2.

Authors:  Tânia F Custódio; Hrishikesh Das; Daniel J Sheward; Leo Hanke; Samuel Pazicky; Joanna Pieprzyk; Michèle Sorgenfrei; Martin A Schroer; Andrey Yu Gruzinov; Cy M Jeffries; Melissa A Graewert; Dmitri I Svergun; Nikolay Dobrev; Kim Remans; Markus A Seeger; Gerald M McInerney; Ben Murrell; B Martin Hällberg; Christian Löw
Journal:  Nat Commun       Date:  2020-11-04       Impact factor: 14.919

Review 10.  Applications of nanobodies in plant science and biotechnology.

Authors:  Wenyi Wang; Jumao Yuan; Changan Jiang
Journal:  Plant Mol Biol       Date:  2020-10-10       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.